FDA
approval
· 2022-12-21
FDA Approved: BRIMONIDINE TARTRATE — Original Application (Apotex Corp.)
Summary
FDA approved the original application for Brimonidine Tartrate by Apotex Corp., adding a generic option for treating glaucoma and ocular hypertension.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for BRIMONIDINE TARTRATE (BRIMONIDINE TARTRATE)